🔎 Trials Near Me

Beranda › Leukemia Limfoblastik Akut › Oklahoma

Uji klinis Leukemia Limfoblastik Akut di Oklahoma

8 studi untuk Leukemia Limfoblastik Akut mencari peserta di lokasi di Oklahoma.

Kota di Oklahoma

Teks studi resmi (Bahasa Inggris)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Hospital Oklahoma City, Oklahoma City
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

  • Board of Regents of the University of Oklahoma Health Sciences Center, Oklahoma City
Menerima pesertaStudi observasional
1 Day – 17 Years · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06274788

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

  • Saint Francis Children's Hospital, Tulsa
Menerima pesertaFase 2
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06533748

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Saint Francis Children's Hospital, Tulsa
Menerima pesertaFase 4
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06289673

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Oklahoma Health Science Center, Oklahoma City
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • University of Oklahoma Health Sciences Center, Oklahoma City
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT01790152

Pilot Imaging Study of Leukemia

  • University of Oklahoma Health Sciences Center, Oklahoma City
Menerima pesertaFase 1
Usia 4 hingga 80 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT03633955

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.